Next Article in Journal
New Trends in Cancer Therapy: Targeting Ion Channels and Transporters
Next Article in Special Issue
Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting
Previous Article in Journal
Safety, Tolerability, and Immunogenicity of Interferons
Previous Article in Special Issue
Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(4), 1187-1201;

A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury

Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
Author to whom correspondence should be addressed.
Received: 16 March 2010 / Revised: 15 April 2010 / Accepted: 19 April 2010 / Published: 20 April 2010
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
Full-Text   |   PDF [3648 KB, uploaded 20 April 2010]   |  


Capsule endoscopy and balloon endoscopy, advanced modalities that allow full investigation of the entire small intestine, have revealed that nonsteroidal anti-inflammatory drugs (NSAIDs) can cause a variety of abnormalities in the small intestine. Recently, several reports show that traditional NSAIDs (tNSAIDs) and acetylsalicylic acid (ASA) can induce small intestinal injuries. These reports have shown that the preventive effect of proton pump inhibitors (PPIs) does not extend to the small intestine, suggesting that concomitant therapy may be required to prevent small intestinal side effects associated with tNSAID/ASA use. Recently, several randomized controlled trials used capsule endoscopy to evaluate the preventive effect of mucoprotective drugs against tNSAID/ASA-induced small intestinal injury. These studies show that misoprostol and rebamipide reduce the number and types of tNSAID-induced small intestinal mucosal injuries. However, those studies were limited to a small number of subjects and tested short-term tNSAID/ ASA treatment. Therefore, further extensive studies are clearly required to ascertain the beneficial effect of these drugs. View Full-Text
Keywords: NSAID; aspirin; small intestine; injury; misoprostol; rebamipide NSAID; aspirin; small intestine; injury; misoprostol; rebamipide

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Fujimori, S.; Gudis, K.; Sakamoto, C. A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury. Pharmaceuticals 2010, 3, 1187-1201.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top